Daniel Schmitt

Daniel Schmitt's AcademicInfluence.com Rankings

Daniel Schmitt

Biology

#10879

World Rank

#14239

Historical Rank

Immunology

#689

World Rank

#711

Historical Rank

Molecular Biology

#1624

World Rank

#1652

Historical Rank

Biochemistry

#1757

World Rank

#1893

Historical Rank

biology Degrees

Download Badge

Biology

Daniel Schmitt's Degrees

PhD Immunology University of California, San Francisco
Masters Biology Stanford University
Bachelors Biochemistry University of California, Berkeley

Similar Degrees You Can Earn

Best Online Master's in Biology

Why Is Daniel Schmitt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Daniel Schmitt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells (1992) (1485)
Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. (2000) (1013)
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha (1996) (890)
GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. (1992) (599)
Macrophage Inflammatory Protein 3α Is Expressed at Inflamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors (2000) (428)
Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria? (2004) (240)
Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double‐blind study vs. placebo (2003) (218)
Gangliosides from Human Melanoma Tumors Impair Dendritic Cell Differentiation from Monocytes and Induce Their Apoptosis (2003) (217)
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. (1997) (198)
Respective involvement of TGF‐β and IL‐4 in the development of Langerhans cells and non‐Langerhans dendritic cells from CD34+ progenitors (1999) (155)
Interleukin‐10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells (1994) (150)
Integration of Langerhans cells into a pigmented reconstructed human epidermis. (1997) (122)
Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements. (2000) (118)
Human dendritic Langerhans cells generated in vitro from CD34+ progenitors can prime naive CD4+ T cells and process soluble antigen. (1995) (113)
PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. (1980) (113)
Functional expression of CD40 antigen on human epidermal Langerhans cells. (1995) (112)
Monocyte‐derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules (1998) (101)
In vitro evaluation of the sensitization potential of weak contact allergens using langerhans-like dendritic cells and autologous T cells. (2000) (98)
The mitochondria-associated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active sphingolipid-specific glycosyltransferases. (2003) (98)
CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. (1997) (97)
Dendritic Cells in Fundamental and Clinical Immunology (2012) (94)
Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes (1997) (91)
Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNFα (2003) (90)
[The dermal dendrocyte]. (1993) (88)
Growth and differentiation of human epidermal cultures used as auto‐ and allografts in humans (1987) (88)
Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. (1983) (84)
Expression and function of B7‐1 (CD80) and B7‐2 (CD86) on human epidermal Langerhans cells (1996) (82)
Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children. (1993) (79)
Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers * (1994) (77)
The disruption of adherens junctions is associated with a decrease of E-cadherin phosphorylation by protein kinase CK2. (2000) (74)
TNF‐α enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL‐12 p40 and IP‐10/CXCL‐10 production (2005) (73)
In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells. (1993) (71)
Expression of corneodesmosin in the granular layer and stratum corneum of normal and diseased epidermis (1997) (70)
The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. (2003) (70)
Dissociation of allergenic and immunogenic functions in contact sensitivity to para-phenylenediamine. (1993) (69)
In vitro primary sensitization of hapten‐specific T cells by cultured human epidermal Langerhans cells—a screening predictive assay for contact sensitizers (1996) (67)
Lichen planus and chronic graft‐versus‐host reaction. In situ identification of immunocompetent cell phenotypes (1982) (66)
Skin lipids. (2003) (66)
Effects of ultraviolet B radiation on human Langerhans cells: functional alteration of CD86 upregulation and induction of apoptotic cell death. (1998) (65)
Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells. (2000) (64)
UV radiation and prostaglandin E2 up-regulate vascular endothelial growth factor (VEGF) in cultured human fibroblasts (2001) (62)
Comparative expression of vascular endothelial growth factor family members, VEGF‐B, ‐C and ‐D, by normal human keratinocytes and fibroblasts (2004) (60)
Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients. (1993) (59)
Quantitative evaluation of two distinct cell populations expressing HLA‐DR antigens in normal human epidermis (1984) (58)
Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells (1983) (57)
Hyperphosphorylation of β-Catenin on Serine-Threonine Residues and Loss of Cell–Cell Contacts Induced by Calyculin A and Okadaic Acid in Human Epidermal Cells☆ (1997) (57)
Lichen planus: study with anti‐human T lymphocyte antigen (anti‐HTLA) serum on frozen tissue sections (1978) (56)
Evidence that filaggrin is a component of cornified cell envelopes in human plantar epidermis. (1996) (55)
Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. (1989) (54)
A longitudinal study of a harlequin infant presenting clinicallyas non‐bullous congenital ichthyosiform erythroderma (1996) (53)
Identification of specific human epithelial cell integrin receptors as VLA proteins. (1990) (52)
Intimate associations between PGP9‐5‐positive nerve fibres and Langerhans cells (1996) (51)
Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P (1997) (50)
Human epidermal Langerhans cells express the mannose‐fucose binding receptor (1998) (50)
Moderate skin sensitizers can induce phenotypic changes on in vitro generated dendritic cells. (2004) (49)
Interkeratinocyte adherens junctions: immunocytochemical visualization of cell-cell junctional structures, distinct from desmosomes, in human epidermis. (1996) (49)
Congenital self‐healing histiocytosis (Hashimoto‐Pritzker): An ultrastructural and immunohistochemical study (1988) (48)
Langerhans-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naive T lymphocytes. (2000) (47)
Use of human reconstructed epidermis to analyze the regulation of β-defensin hBD-1, hBD-2, and hBD-3 expression in response to LPS (2003) (47)
Transforming growth factor‐β1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin‐1 in human dermal fibroblasts (2000) (44)
Fragrance and Contact Allergens in vitro Modulate the HLA–DR and E–Cadherin Expression on Human Epidermal Langerhans Cells (1999) (44)
Human epidermal Langerhans cells express integrins of the beta 1 subfamily. (1991) (43)
Protective effect of zinc on keratinocyte activation markers induced by interferon or nickel. (1995) (43)
Inhibition of human peripheral blood mononuclear cell proliferative response by glycosphingolipids from metacestodes of Echinococcus multilocularis (1996) (43)
In vitro human T cell sensitization to haptens by monocyte-derived dendritic cells. (2000) (43)
Immunogold technique applied to simultaneous identification of T6 and HLA-DR antigens on Langerhans cells by electron microscopy. (1985) (42)
Functional HIV CXCR4 coreceptor on human epithelial Langerhans cells and infection by HIV strain X4 (2001) (42)
In vitro adhesion of human epidermal Langerhans cells to laminin and fibronectin occurs through β1 integrin receptors (1992) (41)
Establishment of nickel-specific T cell lines from patients with allergic contact dermatitis: comparison of different protocols. (1994) (41)
Calcium triggers β‐defensin (hBD‐2 and hBD‐3) and chemokine macrophage inflammatory protein‐3α (MIP‐3α/CCL20) expression in monolayers of activated human keratinocytes (2003) (41)
Immunogold localization of the 97-kD antigen of linear IgA bullous dermatosis (LABD) detected with patients' sera. (1994) (40)
The up-regulation of vascular endothelial growth factor in mutated Ha-ras HaCaT cell lines is reduced by a farnesyl transferase inhibitor. (1999) (40)
Effect of nickel on the activation state of normal human keratinocytes through interleukin 1 and intercellular adhesion molecule 1 expression (1994) (40)
Circulating vascular endothelial growth factor (VEGF) is not a prognostic indicator in malignant melanoma. (1998) (39)
IL‐4 and interferon‐γ differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts (2002) (38)
Dissection of human Langerhans cells' allostimulatory function: The need for an activation step for full development of accessory function (1993) (38)
Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Langerhans cells. (2002) (38)
Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against respiratory syncytial virus (RSV). (2003) (38)
Expression of Substance P Receptors in Normal and Psoriatic Skin (1999) (37)
T cell subsets and Langerhans cells in skin tumours. (1983) (37)
Lymphocyte-epidermis interactions in malignant epidermotropic lymphomas: I. Ultrastructural aspects. (1980) (36)
Differences in responses of interleukin‐1 and tumor necrosis factor α production and secretion to cyclosporin‐A and ultraviolet B‐irradiation by normal and transformed keratinocyte cultures (1997) (36)
Reappearance of CD1a antigenic sites after endocytosis on human Langerhans cells evidenced by immunogoldrelabeling. (1989) (36)
Langerhans Cells of Human Mucosa (1989) (36)
Binding of live conidia of Aspergillus fumigatus activates in vitro‐generated human Langerhans cells via a lectin of galactomannan specificity (2003) (36)
Malignant Langerhans cell tumor: a case with a favorable outcome associated with the absence of blood dendritic cell proliferation. (2003) (35)
Monoclonal antibodies to human epidermal filaggrin, some not recognizing profilaggrin. (1995) (35)
Human monoclonal autoantibodies specific for the bullous pemphigoid antigen 1 (BPAg 1). (1994) (35)
Evaluation of the capacity of dendritic cells derived from cord blood CD34+ precursors to present haptens to unsensitized autologous T cells in vitro. (1998) (35)
Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII (2000) (34)
In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations. (1982) (34)
In vitro effects of ultraviolet B radiation on human Langerhans cell antigen-presenting function. (1995) (34)
In vitro HIV-1 entry and replication in Langerhans cells may clarify the HIV-1 genome detection by PCR in epidermis of seropositive patients. (1992) (34)
Antagonistic effects of IL‐4 and TGF‐β1 on Langerhans cell‐related antigen expression by human monocytes (2002) (34)
In situ characterization of tissue lymphoid cells of cutaneous infiltrates using specific membrane antigens (1979) (34)
Immunoglobulin-producing cells in the inflammatory infiltrates of cutaneous tumors. Immunocytologic identification in situ. (1977) (34)
Acquired perforating dermatosis of diabetes mellitus and renal failure: Further ultrastructural clues to its pathogenesis (1993) (33)
Immunomorphological and ultrastructural aspects of keratinocyte migration in epidermal wound healing (2004) (33)
Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man. (1984) (33)
Morphological, immunological and immunocytochemical identification of lymphocytes extracted from cutaneous infiltrates. (1976) (32)
The semi‐quantitative distribution of T4 and T6 surface antigens on human Langerhans cells (1984) (32)
Immunocytochemical and ultrastructural localization of keratin polypeptides in normal epidermal and mucosal cells and tissues. (1982) (32)
T-cell subsets and Langerhans cells in wart lesions. (1983) (31)
The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skin. (1994) (31)
Expression of gastrin-releasing peptide receptor in human skin. (1996) (31)
Effect of UVB 311 nm irradiation on normal human skin (1997) (30)
Ultrastructural demonstration of T cells in cutaneous tissue sections using specific anti‐human T cell antiserum (1978) (30)
Modulation of cutaneous SP receptors in atopic dermatitis after UVA irradiation. (1998) (30)
CD40 expression in epidermal tumors. (1997) (29)
Human epidermal Langerhans cells express beta 1 integrins that mediate their adhesion to laminin and fibronectin. (1992) (29)
Migration and maturation of human dendritic cells infected with Toxoplasma gondii depend on parasite strain type. (2004) (29)
Immunophenotypic characterization of feline Langerhans cells. (1997) (29)
Culture of putative Langerhans cell bone marrow precursors: characterization of their phenotype. (1988) (29)
Binding specificity of guinea pig anti-alpha-keratin polypeptide sera on human keratinocytes: comparison of their receptors with those of human epidermal cytoplasmic antibodies. (1980) (29)
Glucocorticoid receptor localization in human epidermal cells (1996) (29)
Immunophenotypic and ultrastructural evidence of the langerhans cell origin of the canine cutaneous histiocytoma. (1995) (28)
Contact allergens and sodium lauryl sulphate upregulate vascular endothelial growth factor in normal keratinocytes (1997) (28)
TGFβ Inhibits CD1d Expression on Dendritic Cells (2005) (28)
Simultaneous detection of T6 and HLA-DR antigens distinguishes three cell subpopulations in dispersed normal human epidermal cells. (1984) (27)
In vitro infection of epidermal Langerhans cells with human immunodeficiency virus type 1 (HTLV-IIIB isolate). (1993) (27)
UVA radiation impairs phenotypic and functional maturation of human dermal dendritic cells. (2005) (27)
IL-4 addition during differentiation of CD34 progenitors delays maturation of dendritic cells while promoting their survival. (1998) (27)
Detection of OKT6-positive cells (without visible Birbeck granules) in normal peripheral blood. (1984) (26)
Cell migration and MMP‐9 secretion are increased by epidermal growth factor in HaCa T‐ras transfected cells (1998) (26)
Immunogold labeling of keratin filaments in normal human epidermal cells with two anti-keratin monoclonal antibodies. (1986) (25)
Evidence of increased keratinocyte proliferation in air-liquid interface cultures of non-bullous congenital ichthyosiform erythroderma. (1993) (25)
Keratinocytes from junctional epidermolysis bullosa do adhere and migrate on the basement membrane protein nicein through alpha 3 beta 1 integrin. (1994) (24)
A surface glycoprotein complex related to the adhesive receptors of the VLA family, shared by epidermal Langerhans cells and basal keratinocytes. (1989) (24)
Presence of somatostatin in normal human epidermis (1997) (24)
Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies. (1982) (24)
Expression of immune associated surface antigens of keratinocytes in human papillomavirus-derived lesions. (1993) (24)
Substance P and keratinocyte activation markers: An in vitro approach (1996) (23)
Major antigenic epitopes of bullous pemphigoid 230 kDa antigen map within the C‐terminal end of the protein. Evidence using a 55 kDa recombinant protein (1995) (23)
Immunohistologic study of cellular populations of histiocytofibromas („dermatofibromas”) (1984) (22)
Papilloma viruses, warts, carcinoma and Langerhans cells. (1993) (22)
Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate (2010) (22)
Identification of mononuclear cells infiltrating basal cell carcinomas. (1976) (22)
Gamma interferon potently induces tryptophanyl-tRNA synthetase expression in human keratinocytes. (1993) (22)
Monoclonal anti thymic cell antibodies detecting epidermal cells. (1984) (22)
Effect of various metals on intercellular adhesion molecule-1 expression and tumour necrosis factor alpha production by normal human keratinocytes (2004) (22)
A possible role for human papillomaviruses and c-myc, c-Ha-ras, and p53 gene alterations in malignant cutaneous lesions from renal transplant recipients. (1996) (22)
Ras-transfection up-regulated HaCaT cell migration: Inhibition by Marimastat (2004) (21)
Sclerosing lipogranuloma of the male genitalia: ultrastructural study (1981) (21)
Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells (2001) (21)
Detection of human papillomavirus DNA in CaSki and HeLa cells by fluorescent in situ hybridization. Analysis by flow cytometry and confocal laser scanning microscopy. (1993) (21)
Anti‐D47: a monoclonal antibody reacting with the secretory cells of human eccrine sweat glands * (1983) (21)
CD 1‐reactive leukemic cells in bone marrow: Presence of Langerhans cell marker on leukemic monocytic cells (1992) (21)
HLA class I antigen (heavy and light chain) expression by langerhans cells and keratinocytes of the normal human epidermis: ultrastructural quantitation using immunogold labelling procedure (2004) (21)
Role of specific successive contacts between extracellular matrix proteins and epidermal Langerhans cells in the control of their directed migration. (1995) (21)
Tumour necrosis factor (TNF) soluble receptors in malignant melanoma: Correlation with soluble ICAM-1 level (1996) (20)
Fibronectin upregulates in vitro generation of dendritic Langerhans cells from human cord blood CD34+ progenitors. (1997) (20)
Hyperphosphorylation of beta-catenin on serine-threonine residues and loss of cell-cell contacts induced by calyculin A and okadaic acid in human epidermal cells. (1997) (20)
Epidermal Langerhans cells and HIV-1 infection. (1993) (20)
Characterization of human CD34+ derived dendritic/Langerhans cells (D-Lc). (1995) (20)
Subclustering of CD1 monoclonal antibodies based on the reactivity on human Langerhans cells. (1986) (20)
Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors (2005) (19)
Flow cytometry sorting of unlabelled epidermal Langerhans cells using forward and orthogonal light scatter properties. (1985) (19)
Expression of PGP9.5 on Langerhans' cells and their precursors. (2000) (19)
DMC1: a monoclonal antibody produced from histiocytosis X cells which reacts with the native CD1a molecule of human epidermal Langerhans cells. (1989) (19)
Thymoma and lupus erythematosus. Report of 3 cases. (1983) (19)
Epidermal and mucosal dendritic cells and HIV1 infection. (1994) (19)
Interaction of Human Epidermal Langerhans Cells with HIV‐1 Viral Envelope Proteins (gp 120 and gp 160s) Involves a Receptor‐mediated Endocytosis Independent of the CD4 T4A Epitope (1991) (19)
A potential role for CD1a molecules on human epidermal Langerhans cells in allogeneic T-cell activation. (1991) (18)
Calcium triggers beta-defensin (hBD-2 and hBD-3) and chemokine macrophage inflammatory protein-3 alpha (MIP-3alpha/CCL20) expression in monolayers of activated human keratinocytes. (2003) (18)
Tumour necrosis factor (TNF) soluble receptors in malignant melanoma: correlation with soluble ICAM-1 levels. (1996) (18)
In vitro T cell response to staphylococcal enterotoxin B superantigen in chronic plaque type psoriasis. (1995) (18)
Effects of CD40 ligation on human keratinocyte accessory function (1998) (17)
A combined method for detection of cell surface marker expression and bromodeoxyuridine (BrdU) uptake by epidermal cells in suspension. (1989) (17)
In vitro HIV1 infection of CD34+ progenitor-derived dendritic/Langerhans cells at different stages of their differentiation in the presence of GM-CSF/TNF alpha. (1996) (17)
Phenotypic and functional outcome of human monocytes or monocyte-derived dendritic cells in a dermal equivalent. (2001) (17)
UVA1 and UVB radiation but not PGE2 stimulate IL-8 release in normal human keratinocytes (1999) (17)
cis‐UROCANIC ACID FAILED TO AFFECT in vitro HUMAN LANGERHANS CELL ALLOSTIMULATORY FUNCTION (1995) (17)
α1‐Microglobulin: a new antigenic component of the epidermo‐dermal junction in normal human skin (1985) (17)
ORIGIN OF REED-STERNBERG CELL (1977) (17)
AIDS and Langerhans cells: CD4 antigenic site density modification evidenced by single-cell immunogold labeling. (1989) (17)
Cell-cell junctions in acantholytic diseases (2001) (17)
Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus (2004) (17)
CD40 ligation alters the cell cycle of differentiating keratinocytes. (2000) (17)
Ultrastructure of the human mucocutaneous end organ. (1979) (16)
Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts. (2000) (16)
Langerhans cells in S-phase in normal skin detected by simultaneous analysis of cell surface antigen and BrdU incorporation. (1988) (16)
Keratinocyte migration is partially supported by the cell-binding domain of fibronectin and is RGDS-dependent. (1992) (16)
An immunoelectron microscopic localization of wart associated antigens present in human papilloma virus (HPV) infected cells. (1978) (16)
Recent advances of Ultrastructural immunocytochemistry of epidermal Langerhans cells (1985) (15)
Outer membrane protein A (OmpA) activates human epidermal Langerhans cells. (2003) (15)
LICHEN PLANUS: EVALUATION OF CELLS IN SKIN LESIONS AND OF T‐LYMPHOCYTE SUBSETS IN BLOOD (1983) (15)
Antigenic thymus-epidermis relationships. Reactivity of a panel of anti-thymic cell monoclonal antibodies on human keratinocytes and Langerhans cells. (1987) (15)
Expression and endocytosis of integrin VLA receptors for collagen, fibronectin and laminin by normal human keratinocytes. (1991) (15)
Graft-vs-host reaction in skin: histological immunological and ultrastructural studies. (1979) (15)
Withdrawal of TNF‐α after the fifth day of differentiation of CD34+ cord blood progenitors generates a homogeneous population of Langerhans cells and delays their maturation (2003) (15)
In vitro reconstructed mucosa‐integrating Langerhans' cells (2003) (15)
Modulation of a fibrotic process induced by transforming growth factor beta-1 in dermal equivalents (2004) (14)
A combination of MIP-3α and TGF-β1 is required for the attraction of human Langerhans precursor cells through a dermal-epidermal barrier (2001) (14)
Ontogeny of Langerhans cells: phenotypic differentiation from the bone marrow to the skin. (1990) (14)
Interleukin‐4 and interferon‐γ interactions in the induction of intercellular adhesion molecule‐1 and major histocompatibility complex class II antigen expression of normal human keratinocytes (1994) (13)
Contact sensitivity in mice: differential effect of vitamin D3 derivative (calcipotriol) and corticosteroids. (1993) (13)
Modulation of endothelin‐1 in normal human keratinocytes by UVA1/B radiations, prostaglandin E2 and peptidase inhibitors (2000) (13)
Hyperkeratosis lenticularis perstans (Flegel's disease). A light and electron microscopic study of involved and uninvolved epidermis. (1987) (13)
Vascular endothelial growth factor (VEGF) induces human Langerhans cell migration (2001) (13)
In vitro binding and internalization of HIV envelope glycoproteins by human epidermal Langerhans cells does not require the CD4-gp120-binding site. (1990) (12)
Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines (2004) (12)
In vitro dermal intoxication by bis(chloroethyl)sulfide. Effect on secondary epidermization (1998) (12)
Evidence for modulation of human epidermal differentiation and remodelling by CD40 (2003) (12)
Human Epidermal Cell‐Induced Generation of Alloreactive Cytotoxic T‐Lymphocyte Responses against Epidermal Cells (1985) (12)
Thymic Hassall's corpuscles-epidermis antigenic relations defined by a common glycoprotein in man (GP 37). (1984) (12)
Elastic fibres: histological correlation with orcein and a new monoclonal antibody, HB8 (1984) (12)
TGFbeta inhibits CD1d expression on dendritic cells. (2005) (12)
Contribution of the feline Langerhans cell to the FIV model. (1994) (11)
Expression of adhesion receptors in epidermal tumors: correlation with TNF alpha expressing cells. (1995) (11)
Modulation of substance P and somatostatin receptors in cutaneous lymphocytic inflammatory and tumoral infiltrates (2001) (11)
Ultrastructural observation of Charcot-Leyden crystals in mechlorethamine-treated cutaneous lesions of histiocytosis X. (1986) (11)
Electron‐microscopic Observation of a Human Epidermal Langerhans Cell in Mitosis (1993) (11)
ULTRASTRUCTURAL STUTDY OF THE CUTANEOUS ELASTIC FIBRES IN IN LUPUS ERYTHEMATOSUS (1972) (11)
Effect of gamma‐interferon on IL‐1 alpha, beta and receptor antagonist production by normal human keratinocytes (1994) (11)
Epidermotropism of T cells correlates with intercellular adhesion molecule (ICAMI) expression in human papillomavirus (HPV)‐induced lesions (1992) (11)
Growth and differentiation of human keratinocytes on extracellular matrix (2004) (11)
Comparative evaluation of the antiproliferative effect of cyclosporin A and γ-interferon on normal and HPV-transformed keratinocytes by cell counting, MTT assay and tritiated thymidine incorporation (1997) (11)
Annexin 1 regulation in human epidermal cells. (1994) (10)
Expression of ICAM-3 on human epidermal dendritic cells. (1995) (10)
Immune functions of the human skin. Models of in vitro studies using Langerhans cells (1999) (10)
Expression of ICAM‐3/CD50 in normal and diseased skin (1995) (10)
Overexpression of circulating vascular endothelial growth factor (VEGF) in leukocytoclastic vasculitis (1999) (10)
Immunocytological characterization of the mycosis fungoides tumour cell. (1977) (10)
Expression of neuropeptides on human epidermal Langerhans cells. (1995) (10)
In vitro sensitization of human T cells with hapten-treated Langerhans cells: a screening test for the identification of contact allergens. (1996) (9)
Characterization of dendritic cell differentiation pathways from cord blood CD 34 1 CD 7 1 CD 45 RA 1 hematopoietic progenitor cells (2000) (9)
Novel Protein Kinase C and Matrix Metalloproteinase Inhibitors of Vegetable Origin as Potential Modulators of Langerhans Cell Migration following Hapten-Induced Sensitization (2004) (9)
Plasma vascular endothelial growth factor levels in scleroderma are not correlated with disease activity. (2000) (9)
Use of Tissue Distribution Studies to Determine the Specificity of Monoclonal Antilymphocyte Antibodies (1984) (9)
A combination of MIP-3alpha and TGF-beta1 is required for the attraction of human Langerhans precursor cells through a dermal-epidermal barrier. (2001) (9)
Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions. (1982) (9)
Studies of compounds that enhance sphingolipid metabolism in human keratinocytes 1 (2006) (9)
Quantitative assessment of feline epidermal Langerhans cells (1997) (9)
Cross-reactivity of Anti-lymphocyte Monoclonal Antibodies on Human Skin Components (1986) (9)
[Dendritic cells in dogs and cats: models of study in human pathology]. (1995) (9)
Human epidermal basal keratinocytes express CDw29 antigens (1989) (9)
Comparative phenotypic and ultrastructural characteristics of OKT6-positive cells in normal peripheral blood (adult and infant), in cord blood and in epidermis. (1986) (9)
Huan normal dermal fibroblasts express somatostain receptors (1999) (9)
Effects of thermal shocks on interleukin-1 levels and heat shock protein 72 (HSP72) expression in normal human keratinocytes (2004) (8)
Accessory function of human Langerhans cells in the primary allogeneic T-cell response. (1992) (8)
Neuron-specific enolase is a marker of cutaneous Langerhans' cell histiocytosis ("X")-a comparative study with S100 protein. (1991) (8)
[Preservation of cutaneous structures of egyptian mummies. An ultrastructural study]. (1994) (8)
Suppressive effect of monosaccharides on ICAM-1/CD54 expression in human keratinocytes (1997) (8)
In vitro effect of a spa water on the migratory and stimulatory capacities of human Langerhans calls. (2002) (8)
Analytical methods for evaluation on whole cells of human papillomavirus infection. (1995) (8)
Cleavage of Langerhans cell surface CD1a molecule by trypsin. (1989) (8)
[Cutaneous immune system]. (1994) (7)
Eosinophilic granuloma of bone and biochemical demonstration of 49‐kDa CD1a molecule expression by Langerhans‐cell histiocytosis (1991) (7)
Intimate associations between Langerhans cells and nerve fibers (1994) (7)
In vitro migration capacity of epidermal Langerhans cells. (1995) (7)
Expression of somatostatin on Langerhans cells. (1995) (7)
In vitro effects of a spa water on the migratory and stimulatory capacities of human epidermal Langerhans cellsM.J. Staquet, J. Peguet-Navarro, F. Latourre, A. Richard, A. Rougier, (2000) (7)
Electronmicroscopic study of canine cutaneous histiocytoma: a benign Langerhans cell tumor. (1995) (7)
An anti-lymphocyte monoclonal antibody (HB8) which cross reacts with human dermal elastic fibers. (1984) (7)
Ultrastructural quantitation of desmosome and differentiation-related keratinocyte membrane antigen (2004) (7)
[Monoclonal antibodies (BL7 and BL9) having crossed reactivity with cells of the human epidermis]. (1982) (7)
Oral photochemotherapy in lichen planus (LP) and mycosis fungoides (MF): ultrastructural modifications of the infiltrating cells. (1979) (7)
Detection of low copy numbers of HPV DNA by fluorescent in situ hybridization combined with confocal microscopy as an alternative to in situ polymerase chain reaction. (1998) (7)
Comparative study of in vitro CD1a and HLA-class I antigens endocytosis by human thymocytes and Langerhans cells. (1988) (6)
Elastic fibres: histological correlation with orcein and a new monoclonal antibody (1984) (6)
Active cell membrane mechanisms involved in the exclusion of RH 123 allow distinction between normal and tumoral cells (1994) (6)
Localized pain following contact with liquids (1997) (6)
Differences of reactivity to interferon γ in HeLa and CaSki cells: a combined immunocytochemical and flow-cytometric study (2005) (6)
Alpha 1-microglobulin: a new antigenic component of the epidermo-dermal junction in normal human skin. (1985) (6)
S100 protein and neuron‐specific enolase on monocytic leukemic CD1+ cells, probable precursors of Langerhans cells (1993) (6)
[Adhesion molecules and inflammatory dermatoses]. (1994) (6)
Cyclosporin A does not modify Langerhans' cell number and distribution in normal human skin. (1989) (6)
[Immunohistological identification of histiocytosis X cells. Diagnostic value]. (1983) (6)
[Epithelial dendritic cells and HIV-1 infection in vivo and in vitro]. (1995) (6)
Cutaneous hypermelanosis and intramelanotic lipid droplets. (1980) (6)
Defective leukocytotaxia and recurrent staphylococcal infecion: deficiency of leukocytotaxia and abnormal granulocytes associated with increase serum IgE levels in an adult with recurrent staphylococcal infection. (1978) (6)
Immunohistochemical characterisation of probable intravascular haematopoiesis in the vasa rectae of the renal medulla in acute tubular necrosis. (1994) (6)
Effects of Retinoic Acid on lnterleukin-1α and -1β Expression by Normal Human Keratinocytes Cultured in Defined Medium (1993) (6)
Effects of trypsin on the in situ identification of epidermal cell membrane antigens (1987) (6)
Effects of retinoic acid on interleukin-1 alpha and -1 beta expression by normal human keratinocytes cultured in defined medium. (1993) (5)
Laser scanning confocal microscopy and quantitative microscopy with a charge coupled device camera improve detection of human papillomavirus DNA revealed by fluorescence in situ hybridization (1994) (5)
[Langerhans cells: methods of identification]. (1984) (5)
In vitro determination of sunscreen immune protection factors (2000) (5)
Induction of intercellular adhesion molecule 1 expression on normal human keratinocytes by retinoic acid: comparison of cultured keratinocytes and skin explants. (1994) (5)
Inhibitory effect of IL-10 on human Langerhans cell antigen presenting function. (1995) (5)
Human normal dermal fibroblasts express somatostatin receptors. (1999) (5)
Specific anti-hairy cell and anti-B cell antisera: characterization of surface antigens and origin of hairy cells. (1980) (5)
Comparative nuclear morphometric analysis of aggressive and non-aggressive squamous cell carcinomas of the skin. (1997) (5)
[Cutaneous histiocytosarcoma: clinical, immunohistochemical and ultrastructural aspects; difficulties of study and problems of nosology (author's transl)]. (1980) (5)
[Contribution of monoclonal antibody D 47 in the study of sweat gland pathology]. (1985) (5)
[Langerhans cell migration. An essential step in the induction of contact hypersensitivity]. (2002) (5)
Follow‐up of circulating ICAM‐1 in malignant melanoma: correlation with the clinical course of the disease (1996) (5)
Ultrastructural studies of cultured human epithelial sheets used as skin allografts (2004) (5)
Modified epidermal lipid composition in air-exposed culture of non-bullous congenital ichthyotic erythroderma (NBCIE) keratinocytes (2004) (4)
A set of glycoproteins recognized by A2B5 antibody with major bands at 55 and 76 kDa is overexpressed in human head and neck squamous cell carcinomas. (2003) (4)
Immunohistochemical detection of p53 protein in cutaneous lesions from transplant recipients harbouring human papillomavirus DNA (1994) (4)
[Antigen presentation at the level of the skin. Role of Langerhans cells]. (1990) (4)
IL-10 is unable to downregulate VEGF expression in human activated keratinocytes (2002) (4)
[Skin-T lymphocyte-thymus interactions : a new approach in cutaneous immunopathology (author's transl)]. (1981) (4)
Expression of Neuron‐specific Enolase Immunoreactivity by Cutaneous and Extracutaneous Langerhans‐cell Histiocytoses (“X”) (1992) (4)
Reactivity pattern of anti-CD1 and anti-HLA class II monoclonal antibodies with human eccrine sweat glands. (2008) (4)
[SWAN mice. (Swiss antinuclear). Animal models for the study of acute, disseminated lupus erythematosus and amyloidosis. Immunopathological study]. (1971) (4)
[Use of peroxidase-labelled antibodies in immunologic research and diagnosis]. (1971) (4)
Human B-lymphocyte heteroantigens: direct evidence for specificities not shared by monocytes. (1978) (4)
[Autologous and allogeneic mixed lymphocyte-epidermal cell cultures in man. In vitro approach to lymphoepidermal interactions]. (1982) (4)
Immune response of the skin (1995) (4)
Expression of ICAM-3/CD50 in normal and diseased skin (1994) (4)
High level of CD1a putative peripheral blood precursors of epidermal Langerhans cells after bone marrow transplantation. (1991) (4)
A simple technique for immunoelectronmicroscopic localization of Ig on tissue sections with special reference to cutaneous pathology (1977) (4)
Ultrastructural immunogold labelling of human langerhans cells enriched epidermal cell suspension (2004) (4)
Helper phenotype of the Sézary cell: Direct ultrastructural evidence using monoclonal antibodies (2004) (4)
Study of immune-associated antigens (IL-1 and ICAM-1) in normal human keratinocytes treated by sodium lauryl sulphate (2004) (4)
Effect of different sensitizing haptens on intercellular adhesion molecule-1 expression and cytokine production by normal human keratinocytes (1995) (4)
In situ identification of cycling Langerhans cells in normal human skin (2004) (4)
[The Langerhans cell: from in vitro production to use in cellular immunotherapy]. (2001) (4)
Langerhans cell induced cytotoxic T‐cell responses against normal human epidermal cell targets: in vitro studies (1985) (4)
[Malpighian epithelia infected by DNA viruses and Langerhans cells]. (1989) (4)
Do circulating OKT6-reactive cells belong to Langerhans cell lineage? (1988) (4)
Evidence that Langerhans cells migrate to regional lymph nodes during experimental contact sensitization in dogs. (1995) (4)
Expression of PGP 9 . 5 on Langerhans ' Cells and Their Precursors (2000) (4)
When integrated in a subepithelial mucosal layer equivalent, dendritic cells keep their immature stage and their ability to replicate type R5 HIV type 1 strains in the absence of T cell subsets. (2004) (3)
[Langerhans cell: CD1 antigens and the Birbeck granule]. (1988) (3)
Mixed skin cell‐lymphocyte culture reaction (MSLR) in man as an in vitro model of lympho‐epidermal interactions: FACS analysis of epidermal cell and T‐cell involved subpopulations (1984) (3)
Chronic bullous dermatosis of childhood. Immunological and ultrastructural studies on the melanocyte--dermal junction. (1978) (3)
Ultrastructural identification of human tonsil T-lymphocytes by peroxidase-conjugated anti-HTLA serum (1976) (3)
Thalidomide does not affect in vitro mixed skin cell lymphotyte reactions (1995) (3)
[Lichen planus. Study of the T-lymphocyte population and Langerhans cells using monoclonal antibodies]. (1983) (3)
Influence of Retinoic Acid on Epidermal Wound Healing in Man (1981) (3)
Human in vitro T cell sensitization using hapten-modified epidermal Langerhans cells. (1993) (3)
Low incidence of C‐Ha‐ras gene mutations in benign and malignant cutaneous lesions from transplant recipients (1993) (3)
HB8: a monoclonal antibody recognizing elastic fibre microfibrils (1986) (3)
IL-1 up-regulates expression of IL-2 and IL-3 as well as TH2-type cytokines (IL-5, IL-6, IL-9, IL-13) in activated mouse bone marrow-derived mast cells (1994) (3)
Ultrastructural localization of binding sites of sera from patients with linear IgA bullous dermatosis (2004) (3)
Topical application of isotretinoin did not modify human Langerhans cell allostimulatory function. (1994) (2)
Cell-cell junctions in acantholytic diseases. Junction proteins in nonimmune and autoimmune acantholysis. (2001) (2)
Inhibitory effects of ultraviolet B on human Langerhans cell antigen presenting function. (1995) (2)
Expression of the human progenitor cell antigen (CD34) in cutaneous mesenchymal tumours (1994) (2)
Ultrastructural characteristics of hybrids derived from normal and hand wart keratinocytes after serial passages. (1989) (2)
[Contribution of the electron microscope to study of the cutaneous lesions in lupus erythematosus]. (1971) (2)
In vitro HIV-1 infection of isolated epidermal Langerhans cells with a cell-free system. (1995) (2)
Expression of Annexin I in freshly isolated human epidermal cells and in cultured keratinocytes (2004) (2)
[Dermo-epidermal junction: current update]. (1994) (2)
Topically applied ascorbic acid helps to restructure chronically photodamaged human skin. (2002) (2)
[Hemicorporeal verrucous nevus. Ultrastructural study]. (1971) (2)
In vitro effect of a spa water on the migratory and stimulatory capacities of human Langerhans cells : Cosmetics as adjunctive therapy in dermatology: some applications (2002) (2)
Endocytosis of class II histocompatibility antigens and formation of intracytoplasmic granules at the final differentiation stage of human B lymphocytes. (1983) (2)
Loratadine downregulates ICAM-1 expression on human keratinocytes and Langerhans cells (1996) (2)
Reactivity of anti-HLA class I polymorphic monoclonal antibodies with normal human skin. (1987) (2)
Interferon gamma-induced PNA-binding glycoproteins as markers of human keratinocyte differentiation: biological evidence using protein kinase C agonists, antagonists and retinoic acid (1997) (2)
[Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology]. (1986) (2)
[Study of normal and pathological keratinization using anti-keratin polypeptide sera (author's transl)]. (1980) (2)
The antigen presenting capacity of human epidermal Langerhans cells. (1994) (2)
La cellule de Langerhans: méthodes d'identification. (1984) (2)
Differences in reactivity to cyclosporin A and interferon-gamma of normal and HPV-transformed keratinocytes. (1996) (2)
Detection of human papillomavirus DNA in genital lesions by enzymatic in situ hybridization with Fast Red and laser scanning confocal microscopy (1997) (2)
Immunologic and morphologic studies of B-cell lymphoma with cutaneous involvement. Report of a case. (1977) (2)
[The desmosome: structure, function and acquired pathology]. (1994) (2)
Feline Langerhans cells migrate from skin and vaginal mucosa to regional lymph nodes during experimental contact sensitization with fluorescein isothiocyanate. (1998) (2)
Quantification of HTLA-positive lymphocytes during oral photochemotherapy of psoriasis (1979) (2)
IL-13 Is More Efficient than IL-4 for Recruiting Langerhans Cell Precursors from Peripheral CD14+ Monocytes (2002) (2)
Comparative Reactivity of a Panel of Monoclonal Antibodies on Yucatan Mini‐Pig and Human Skin (1986) (2)
[Immunocytological study of cutaneous malignant lymphomas. Classification (author's transl)]. (1978) (1)
Adhesion of epidermal Langerhans cells to various extracellular matrix proteins might influence their migration behavior (1993) (1)
Application of the biotin-avidin system for ultrastructural identification of suppressor/cytotoxic lymphocytes in oral lichen planus (1981) (1)
[Immunofluorescence and immunoperoxidase: a comparison for sensitivity in cutaneous immunopathology (author's transl)]. (1978) (1)
Potentializing effect of ketoconazole on cyclosporin A-induced inhibition of keratinocyte DNA synthesis. (1994) (1)
[Immunofluorescence techniques applied to the diagnosis of autoimmune bullous skin diseases of the dermoepidermal junction]. (1993) (1)
Expression of common cytoplasmic antigens by epithelial cells of thymus and epidermis (2004) (1)
Langerhans cells (LC) in normal skin and their bone marrow CDI positive progenitors in s-phase (1989) (1)
Effects of chronic sunlight exposure on the immunological function of the human epidermis (1995) (1)
Ultrastructural localization of binding sites for linear IgA bullous dermatosis (LABD) antibodies (1993) (1)
Human epidermal langerhans cells express the mannosefucose binding receptor (1998) (1)
Effects of cytokines on the gamma interferon-induced tryptophanyl-tRNA synthetase expression by human keratinocytes. (1994) (1)
The effect of trypsin on CD1a molecule of human thymocytes. (1990) (1)
Ultrastructure of hybrids derived from electric pulse fusion of human HeLa cells and murine 3T3.4E cells. (1990) (1)
[Ultrastructural study of cutaneous lesions in Jadassohn Lewandowsky syndrome]. (1973) (1)
MIXED SKIN CELL LYMPHOCYTE CULTURE REACTION (MSLR) IN PSORIASIS (1983) (1)
Vitiliginous achromia with malignant melanoma (1977) (1)
[Importance of image analysis in immunoelectron microscopy. Visualization of heterogeneous reactivity of sera from patients with linear IgA dermatitis bullosa with structures of the dermo-epidermal junction]. (1995) (1)
Expression of cell - cell contact proteins in non-immune mediated acantholytic dermatoses (1998) (1)
Toxoplasma gondii: comparison of human CD34+ and monocyte-derived dendritic cells after parasite infection. (2007) (1)
Human reconstructed cutaneous melanoma as a new functional model of tumor cell invasion (1998) (1)
TNF alpha expressing cells in epidermal tumors: correlation with ICAM-1 induction on keratinocytes and Langerhans cell distribution. (1994) (1)
Antibodies against human filaggrin that do not recognize its precursor — Profilaggrin in keratohyalin granules (1994) (1)
[Current data on Langerhans cells]. (1986) (1)
Dissection of human Langerhans cell allostimulatory function, modulation by interferon-gamma. (1993) (1)
In vitro hapten treatment stimulates the migration of human epidermal Langerhans cells (1993) (1)
[The spleen in "nude" mice: an immunological and immunocytochemical study (author's transl)]. (1976) (1)
[HIV envelope proteins are bound by human epidermal Langerhans cells by a binding site which differs from the site on the CD4 molecule, and are internalized by receptor endocytosis]. (1989) (1)
[Study of inclusions of lupus erythematosus. Particular aspects of the cell membrane]. (1971) (1)
Oligoclonal T cell response in psoriatic cutaneous lesions (1994) (1)
A novel antigen of the dermal-epidermal junction defined by an anti-CD1b monoclonal antibody (NU-T2) (2004) (1)
Langerhans Cells and HIV Infection (1995) (1)
Cutaneous molecular paleobiology: a new line in dermatological research (1993) (1)
Quantitative analysis of HLA-DR antigen expression by normal human epidermal cells (light microscopy and flow cytometry sorting) (1984) (1)
[B-lymphocytes subpopulation. Rapid identification with a histoimmunological method (author's transl)]. (1975) (1)
[Ultrastructural aspects of virus-like inclusions in the skin of Lupus erythematosus acutus and chronicus]. (1971) (1)
Differential toxicity on monocytes and monocyte‐derived dendritic Cells: a new tool to differentiate allergens from irritants? (2007) (0)
[Skin-T lymphocyte-thymus interactions: a new approach in cutaneous immunopathology (author's transl)]. (1982) (0)
Contents, Vol. 157, 1978 (1978) (0)
Gangliosides Purified from Human Melanoma Tumors Alter the Phenotypic and Functional Differentiation of Monocyte-derived Dendritic Cells and Induce their Apoptosis (0)
Studies of human epidermal cell differentiation using monoclonal antibodies (1984) (0)
[Immunologic and ultrastructural correlations during ontogenesis of the dermo-epidermal basal membrane in the mouse]. (1971) (0)
[Detection of human papillomavirus DNA by in situ hybridization and gene amplification]. (1994) (0)
The Editors reply (1981) (0)
Kinetics of the evolution of birbeck granule-related structures in langerhans cells generated from human CD34+ hematopoietic progenitors by using electron microscopic investigation (1994) (0)
Regulation of cadherin/catenin complex by phosphorylation on serine-threonine residues in human keratinocytes (1998) (0)
Phenotypic analysis of human langerhans cells after in vitro treatment with a strong allergen or an irritant (1998) (0)
[Paraneoplastic ichthyosis. Ultrastructural study]. (1976) (0)
[A chronological study of thymic crystalline inclusions and autoimmune disorders in Swan and NZB mice (author's transl)]. (1975) (0)
Determination of sunscreen immune protection factors using human dendritic cell suspensions. (2004) (0)
[Immunological and immunocytochemical studies of the inflammatory infiltrating cells of cutaneous tumors]. (1977) (0)
A method correlating the presence of cell surface markers with bromodeoxyuridine (BrdU) uptake in epidermal cell suspensions (1989) (0)
Production of dendritic cells in vitro from CD14 + monocytes, especially for the realization of cell models and / or tissue suspension, monolayers and tridimentionnels; Use of these models (2001) (0)
Ultrastructural and quantitative evaluation of HLA-DR antigen densities of Langerhans cells (LC) and indeterminate cells (IC) using immunogold labelling (1984) (0)
Human monoclonal auto-antibodies specific for the bullous pemphigold antigen 1 (BPAg1) (1994) (0)
Incidence of human papillomavirus type 33 in premalignant and malignant skin lesions from organ transplant recipients. (1997) (0)
Gamma interferon-induced PNA-binding glycoproteins: Late maturation markers of epidermal keratinocytes (1998) (0)
[Quantitative immunocytochemical study of plasma cells in the stroma reaction in malignant skin tumors (author's transl)]. (1980) (0)
[Ultrastructural study of dermal vascular lesions in the trisymptomatic syndrome of Gougerot (Leukocytoclasic vasculitis)]. (1971) (0)
[Comparison between results of leukocyte migration inhibition test and skin hypersensitivity of tuberculin in man]. (1971) (0)
[Interspecies somatic hybrid cultures from human epidermal cells and 3T3-4E mouse fibroblasts]. (1984) (0)
Detection of HIV-specific DNA sequences in epidermal Langerhans cells infected in vitro by means of a cell-free system (2004) (0)
Bullous pemphigold associated with chronic B-lymphocytic leukemia: The antibody against the 230 kD-protein is not produced by leukemic cells (1997) (0)
A murine CDIa monoclonal antibody obtained after immunization with histiocytic cells (1989) (0)
[Locomotion of human circulating lymphocytes methodological aspects "in vitro" (author's transl)]. (1980) (0)
Early or late expression of Ia antigen on mouse keratinocytes in allergic contact dermatitis? (1994) (0)
[Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)]. (1978) (0)
[Bias of index of T-lymphocytes and chronic inflammatory dermatoses]. (1994) (0)
Expression of PGP9.5 by Langerhans cells: A neuronal property? (1997) (0)
[Congenital cutaneous atrophy in multiple plaques. A new clinical form of mastocytosis?]. (1983) (0)
Role of H-ras oncogene mutation on cellular migration and metalloproteinase secretion in human keratinocytes (1998) (0)
[Skin and neuromediators]. (1996) (0)
In Vitro Chemotaxis of Lymphocytes in Cutaneous Lymphoma (1982) (0)
[Ultrastructural study of the bulla in hepatic cutaneous porphyria]. (1972) (0)
A Screening Predictive Assay for Fragrance Contact Allergens. In vitro Modulation of HLA-DR and E-Cadherin Phenotypic Expression on Human Epidermal Langerhans Cells. (2001) (0)
[Origin of the Reed-Sternberg cell]. (1978) (0)
THE MITOCHONDRIA-ASSOCIATED-ER SUBCOMPARTMENT (MAM FRACTION) OF RAT LIVER CONTAINS HIGHLY ACTIVE SPHINGOLIPID-SPECIFIC GLYCOSYLTRANSFERASES (2003) (0)
Role of the interaction of fibronectin with epidermal Langerhans cells in regulating their migratory pathway. (1995) (0)
[Ultrastructural identifaction of human T lymphocytes using a peroxidase-conjugated anti-HTLA serum]. (1977) (0)
Proteic allergens captation by dendritic cells generated from cord blood progenitors and efficient presentation in primary response (1998) (0)
[Cutaneous sarcoid granuloma: cytoimmunological study of the lymphocytes (freed cells and tissue sections) (author's transl)]. (1978) (0)
[Clear cell acanthoma. Ultrastructural and immunohistological study]. (1983) (0)
[Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies]. (1982) (0)
Presence of abnormal circulating CD34+ progenitors in adult langerhans cell histiocytosis (1998) (0)
Altered expression of a new antigen of the dermal-epidermal junction (NU-T2 DEJ Ag) in junctional epidermolysis bullosa (2005) (0)
Effect of extracellular matrix on in vitro Langerhans cells migration (1994) (0)
[Ultrastructural analogy between renal lesions in Swan mice with antinuclear antibodies and those of human disseminated acute lupus erythematous]. (1972) (0)
OKT8 human phenotype expressed by Papio papio monkey lymphocytes. (1982) (0)
[Cutaneous immunity and environment]. (1991) (0)
[Langerhans cells generated in vitro: advances and application]. (1999) (0)
DETECTION OF HUMAN PAPILLOMAVIRUS DNA BY FLOW CYTOMETRY WITH THE USE OF POLYMERASE CHAIN REACTION AND FLUORESCENCE IN SITU HYBRIDIZATION (1993) (0)
A longitudinal study of a harlequin infant evolving towards non-bullous congenital ichthyosiform erythroderma (NBCIE) (1994) (0)
Expression of somatostatin on human epidermal cells (1994) (0)
Exogenous nicein supports adhesion and migration of junctional epidermolysis bullosa keratinocytes through integrin alpha 3 beta1 (1994) (0)
[Antigens recognised by monoclonal anti-lymphocyte antibodies can have unexpected tissue localizations]. (1983) (0)
Skin equipment having langerhans' cell (1997) (0)
[Comparative histological, histo-immunological and ultrastructural study of healthy and pathological skin in acute disseminated lupus erythematosus and chronic lupus erythematosus]. (1973) (0)
Correlation between activation of eosinophils and loss of α6β4 reactivity in bullous pemphigoid lesional skin (1994) (0)
[Generation of cytotoxic lymphocytes in lympho-epidermal mixed cultures in man]. (1984) (0)
Immunohistochemical Localization of T-Lymphocytes in Cutaneous Tissue Sections (1980) (0)
Effect of different haptens on intercellular adhesion molecule-1 expression and cytokine production by cultured normal human keratinocytes (1994) (0)
Effect of cyclosporin‐A and UVB on cell prollferation and cytokine secretion by different epithelial cell lines carrying or not human papillomavirus (1995) (0)
[Ultrastructural localization of antibodies fixed at skin level in lupus erythematosus: immunolabeling with cytochrome c (author's transl)]. (1974) (0)
The Langerhans cell = La cellule de Langerhans : proceedings of the Second Workshop on Langerhans cells, held in Lyon (France), April 21-22, 1988 (1988) (0)
Inﬂammatory Protein 3 a Is Expressed at Inﬂamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors By (2000) (0)
Action of the “nude” gene on pigmentation of the coat in C57 black and C3H mice (1978) (0)
Identification and functions of human Langerhans and epidermal indeterminate cells participating in the in vitro generation of alloreactive human cytotoxic T cells (1984) (0)
[Congenital atrophoderma in multiple plaques. A new clinical form of mastocytosis?]. (1983) (0)
Expression of PGP9.5 by non innervated langerhans cells: A neuronal property ? (1998) (0)
9. Skin cancers in organ transplant recipients (1996) (0)
Effects of ultraviolet B radiation on in vitro hapten T-cell sensitization by human langerhans cells. (1998) (0)
[Immunocytological identification of intratissular lymphocytes. Technical aspects and preliminary results]. (1975) (0)
[The Reed-Sternberg cell: absence of specific antigens on the surface of B (HBLA) and T (HTLA) lymphocytes]. (1977) (0)
Ultrastructural Demonstration of the Helper Phenotype of Sézary Cells Using Monoclonal Antibodies (1982) (0)
Differential expression of glucocorticoid receptors and annexins in human inflammatory lesions and in epidermal tumors (1994) (0)
Immunoelectron microscopic demonstration of D 47 antigen on isolated human eccrine sweat glands (2004) (0)
Effect of Cis urocanic acid on in vitro human Langerhans cell allostimulatory function (1994) (0)
Detection by Elisa Test of Antibodies to Human Papillomavirus (HPV) Type 16 E7 Oncoprotein in Patients with Benign or Malignant Papillomas from Skin or Mucosa (1994) (0)
Bullous dermatosis of hemo dialysis ultrastructural study of sun exposed skin (1977) (0)
10th Annual Meeting of the Skin Pharmacology Society (1994) (0)
[Palmoplantar keratosis of Darier's disease and multiple abnormalities. Ultrastructural study]. (1971) (0)

This paper list is powered by the following services:

Daniel Schmitt's Academic­Influence.com Rankings

Daniel Schmitt's Degrees

Similar Degrees You Can Earn

Why Is Daniel Schmitt Influential?

Daniel Schmitt's Published Works

Published Works

Daniel Schmitt's AcademicInfluence.com Rankings